Oppenheimer & Co’s Tenet Healthcare THC Stock Holding History

Oppenheimer & Co’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,847	Closed	-$473K	–	1645
2024 Q3	$473K	Hold	2,847	–	–	0.01%	1053
2024 Q2	$379K	Hold	2,847	–	–	0.01%	1100
2024 Q1	$299K	Hold	2,847	–	–	0.01%	1185
2023 Q4	$215K	Buy	+2,847	New	+$180K	﹤0.01%	1259
2022 Q1	–	Sell	-6,185	Closed	-$505K	–	1582
2021 Q4	$505K	Sell	6,185 -6,989	-53%	-$511K	0.01%	1020
2021 Q3	$875K	Hold	13,174	–	–	0.02%	789
2021 Q2	$883K	Buy	13,174 +3,086	+31%	+$191K	0.02%	800
2021 Q1	$525K	Buy	+10,088	New	+$510K	0.01%	945
2016 Q3	–	Sell	-19,267	Closed	-$533K	–	1308
2016 Q2	$533K	Sell	19,267 -1,500	-7%	-$44.3K	0.02%	770
2016 Q1	$601K	Sell	20,767 -650	-3%	-$16.9K	0.02%	690
2015 Q4	$649K	Buy	+21,417	New	+$702K	0.02%	688
2015 Q3	–	Sell	-4,214	Closed	-$244K	–	1457
2015 Q2	$244K	Buy	+4,214	New	+$215K	0.01%	1190
2013 Q3	–	Sell	-4,814	Closed	-$221K	–	1364
2013 Q2	$221K	Buy	+4,814	New	+$216K	0.01%	1060

Other funds holding THC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Oppenheimer & Co's THC Position: Q4 2024 in Review

Oppenheimer & Co sold out of Tenet Healthcare (THC) in Q4 2024, closing a stake of 2,847 shares — an estimated $473K sold.

Oppenheimer & Co first reported a position in THC in Q2 2013 and held it in 13 quarters. The position peaked at $883K in Q2 2021. 578 funds tracked by Wall St. Rank hold THC as of Q4 2024.

Oppenheimer & Co reported no remaining Tenet Healthcare position as of Q4 2024 after selling out during the quarter.
Oppenheimer & Co sold 2,847 Tenet Healthcare shares in Q4 2024, an estimated $473K.
Oppenheimer & Co first reported a position in Tenet Healthcare in Q2 2013 and held it in 13 quarters.
Oppenheimer & Co's Tenet Healthcare position peaked at $883K in Q2 2021.
578 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2024.

Based on Oppenheimer & Co's 13F filing for Q4 2024, filed 5 Feb 2025.